Skip to content Skip to navigation
Portsmouth CCG
Call 111 if it is not an emergency
Search

Results for {phrase} ({results_count} of {results_count_total})

Displaying {results_count} results of {results_count_total}

More results...

Generic filters
MENUMENU
  • Home
  • About Us
        • About Portsmouth CCG
          • Our Area
          • Our Member Practices
          • Primary Care Networks
          • Supporting Primary Care this Winter
          • Our Priorities
          • Equality, Diversity and Human Rights
        • Our Governing Board and Primary Care Commissioning Committee
          • Governing Board - Who's Who
          • Meetings and Past Papers
  • Publications
        • Publications and Key Information
          • Lists and Registers
          • Spending Over £25,000
          • Primary Care Rebate Schemes
        • Publication Scheme
          • Who we are and what we do
          • What we spend and how we spend it
          • What our priorities are and how we are doing
          • How we make decisions
          • Policies and Procedures
          • Contractual Sanctions
        • Priorities Committee Statements
          • Area Prescribing Committee
  • Your Health
        • Your Health
          • Guide to Services
          • Which health service should you use?
          • Your GP Practices
          • Pharmacies and Medicines
          • Self-care
          • NHS and Continuing Healthcare
          • Safeguarding
        • Coronavirus (COVID-19)
          • Latest information
          • Coronavirus vaccination
          • Symptoms and testing
          • Support
          • NHS Covid-19 app
        • The flu
          • Winter flu vaccine
  • Hearing From You
        • Hearing From You
          • You said, we did
          • Accessible Information
        • Current Consultations and Engagement
          • Getting end of life care right
        • Previous Consultations and Engagement
          • Patient transport survey for service users
          • Your Big Health Conversation Phase 1
          • Your Big Health Conversation Phase 2
          • Developing how NHS111 helps you
          • Mental health rehabilitation
          • Helping shape IVF services (2014)
          • Other Projects
  • News
  • Contact Us
        • Contact Us
          • Feedback and Complaints
          • Freedom of Information
        • Using your Information
          • How do we use your information?
          • Looking after your personal information
        • Media Enquiries
          • Media Releases
Search

Results for {phrase} ({results_count} of {results_count_total})

Displaying {results_count} results of {results_count_total}

More results...

Generic filters
MENUMENU
  • Home
  • About Us
        • About Portsmouth CCG
          • Our Area
          • Our Member Practices
          • Primary Care Networks
          • Supporting Primary Care this Winter
          • Our Priorities
          • Equality, Diversity and Human Rights
        • Our Governing Board and Primary Care Commissioning Committee
          • Governing Board - Who's Who
          • Meetings and Past Papers
  • Publications
        • Publications and Key Information
          • Lists and Registers
          • Spending Over £25,000
          • Primary Care Rebate Schemes
        • Publication Scheme
          • Who we are and what we do
          • What we spend and how we spend it
          • What our priorities are and how we are doing
          • How we make decisions
          • Policies and Procedures
          • Contractual Sanctions
        • Priorities Committee Statements
          • Area Prescribing Committee
  • Your Health
        • Your Health
          • Guide to Services
          • Which health service should you use?
          • Your GP Practices
          • Pharmacies and Medicines
          • Self-care
          • NHS and Continuing Healthcare
          • Safeguarding
        • Coronavirus (COVID-19)
          • Latest information
          • Coronavirus vaccination
          • Symptoms and testing
          • Support
          • NHS Covid-19 app
        • The flu
          • Winter flu vaccine
  • Hearing From You
        • Hearing From You
          • You said, we did
          • Accessible Information
        • Current Consultations and Engagement
          • Getting end of life care right
        • Previous Consultations and Engagement
          • Patient transport survey for service users
          • Your Big Health Conversation Phase 1
          • Your Big Health Conversation Phase 2
          • Developing how NHS111 helps you
          • Mental health rehabilitation
          • Helping shape IVF services (2014)
          • Other Projects
  • News
  • Contact Us
        • Contact Us
          • Feedback and Complaints
          • Freedom of Information
        • Using your Information
          • How do we use your information?
          • Looking after your personal information
        • Media Enquiries
          • Media Releases
Search

Results for {phrase} ({results_count} of {results_count_total})

Displaying {results_count} results of {results_count_total}

More results...

Generic filters
MENUMENU
  • Home
  • About Us
        • About Portsmouth CCG
          • Our Area
          • Our Member Practices
          • Primary Care Networks
          • Supporting Primary Care this Winter
          • Our Priorities
          • Equality, Diversity and Human Rights
        • Our Governing Board and Primary Care Commissioning Committee
          • Governing Board - Who's Who
          • Meetings and Past Papers
  • Publications
        • Publications and Key Information
          • Lists and Registers
          • Spending Over £25,000
          • Primary Care Rebate Schemes
        • Publication Scheme
          • Who we are and what we do
          • What we spend and how we spend it
          • What our priorities are and how we are doing
          • How we make decisions
          • Policies and Procedures
          • Contractual Sanctions
        • Priorities Committee Statements
          • Area Prescribing Committee
  • Your Health
        • Your Health
          • Guide to Services
          • Which health service should you use?
          • Your GP Practices
          • Pharmacies and Medicines
          • Self-care
          • NHS and Continuing Healthcare
          • Safeguarding
        • Coronavirus (COVID-19)
          • Latest information
          • Coronavirus vaccination
          • Symptoms and testing
          • Support
          • NHS Covid-19 app
        • The flu
          • Winter flu vaccine
  • Hearing From You
        • Hearing From You
          • You said, we did
          • Accessible Information
        • Current Consultations and Engagement
          • Getting end of life care right
        • Previous Consultations and Engagement
          • Patient transport survey for service users
          • Your Big Health Conversation Phase 1
          • Your Big Health Conversation Phase 2
          • Developing how NHS111 helps you
          • Mental health rehabilitation
          • Helping shape IVF services (2014)
          • Other Projects
  • News
  • Contact Us
        • Contact Us
          • Feedback and Complaints
          • Freedom of Information
        • Using your Information
          • How do we use your information?
          • Looking after your personal information
        • Media Enquiries
          • Media Releases

Portsmouth CCG Rebate Policy

On this page

Introduction

Good Practice Principles against which local rebates schemes should be assessed and adopted

Claiming reimbursement

Monitoring

Reference

Appendix 1

1. Introduction

Pharmaceutical companies are offering schemes whereby Clinical Commissioning Groups (CCGs) can receive rebates on dispensed prescription products.  These may be referred to as “Rebate Schemes”, “Local Pricing Agreements” or “Local Discount Schemes”.

Primary care rebates schemes are contractual arrangements offered by pharmaceutical companies or third party companies which offer financial rebates on GP prescribing expenditure for particular branded medicines or prescribable products.

Individual CCGs will need to reach a decision regarding whether it will enter into these rebates or local discount schemes. This policy summarises the main points for consideration and outlines a process for assessing and managing these schemes.

This policy applies to Portsmouth Clinical Commissioning group including all employees, members of the CCG, co-opted members, members of the governing body and committees.

In the interests of transparency it is the duty of all staff to ensure that all declarations of interest are made in accordance with the CCG policy.

Price reductions on branded products are not available when items are prescribed on FP10; the Prescription Pricing Division of the NHSBSA will reimburse dispensing contractors at the manufacturer’s list price.  Hospital Trusts can often negotiate purchasing discounts particularly if a group of Trusts are buying collectively.  In addition, lower prices agreed as a condition of a NICE TA recommendation (Patient Access Scheme or PAS discount) are generally only available to purchasing NHS Trusts. As the discounted price is a condition of the NICE recommendation for provision of the medicine within the NHS, if the NHS does not obtain the discounted price it is not complying with the NICE TA guidance.

The rebate schemes may cover medicinal and non-medicinal products, appliances and assistive technology. The potential value of the rebate scheme and indirect costs associated with administering the scheme should be considered.

Legal advice sought by the London Procurement Partnership (LPP) in 2012 concluded that primary care rebate schemes are not unlawful and are within the powers of CCGs to agree to, provided they meet certain requirements. This advice has been used to inform this policy.


2. Good Practice Principles against which local rebates schemes should be assessed and adopted

2.1 Product related

Rebate schemes should only be considered if the medicine in question is appropriate for Portsmouth CCG patients, and already accepted onto the Portsmouth and South Eastern Hampshire area Local Health Economy Formulary. Acceptance of a rebate scheme should not constrain the existing local decision making processes or formulary development and should not influence treatment decisions for individual patients.  In summary, any financial benefit accrued from these schemes should be viewed as incidental and not as a driver for local population or individual decision-making.

Rebate schemes should only be entered into for UK licensed medicines and be based on use of the medicine in accordance with the SPC. Where there is more than one licensed indication for a medicine, the scheme should cover all indications.  Rebate schemes promoting unlicensed or off-label use will not be entered into.

Primary care rebate schemes should be agreed at a statutory organisational level, they should not be agreed at GP practice level.

Schemes encouraging exclusive use of a particular drug should be avoided and Portsmouth Clinical Commissioning group should not enter into any schemes that preclude them from considering any other schemes subsequently offered by manufacturers of competitor drugs, should they wish to do so. The CCG should not enter into schemes that require them to provide information to a manufacturer about competitor products market share.

Rebate schemes are not appropriate for medicines in Category M and some medicines in Category C of the Drug Tariff, because of the potential wider impact on community pharmacy reimbursement.

Resilience of supply of relevant products is important. The availability of the product should match the likely uptake should the scheme be adopted widely within Portsmouth.  This is not a contractual element but reassurance will be sought that any significant increase or spike in demand can be managed by the company,

2.2 Rebate scheme related

The administrative burden to the NHS of setting up and running the scheme must be factored into the assessment of the likely financial benefit of the scheme, managing the scheme should be minimal once the scheme has been agreed.  Consideration should be given to audit requirements, financial governance, data collection, any other hidden costs and practical issues such as the term of agreement.

All rebate schemes should be considered on their own merits using the same criteria (see appendix 1).

The proposed scheme should not be directly linked to requirements to increase market share or volume of prescribing.  In practice, only schemes that offer a simple discount based on ePACT prescribing data are likely to be approved.  There should be no requirement to collect or submit to the manufacturer any data other than volume of use as derived from ePACT data.

Agreements must meet the requirements of the Data Protection Act and patient confidentially must never be compromised.

A formal written contract is required, signed by both parties to ensure that the terms of the scheme are clear and to maximise legal protection. Agreements should include a right to terminate on notice (i.e. without having to have any reason for doing so) with a sensible notice period e.g. three or six months.

The need for an exit criteria and exit strategy should be considered before a scheme is agreed. It is essential to allow flexibility to respond to emergence of significant new clinical evidence, or significant changes in market conditions.  A shorter notice period should be agreed in these circumstances.

a) The CCG should make public the existence of any schemes that they have agreed to.

b) Information relating to rebate schemes is disclosable under Freedom of Information (FOI). This should be discussed with the manufacturer before any agreement is entered into.  Ideally, redacted non-commercial contracts should be provided as commercially sensitive information is contained in the contract.  This will help the Medicines Management Team differentiate between commercial and non-commercial details and allow the team to reactively respond to such FOI requests.  If a redacted non-commercial contract is not available Portsmouth Clinical Commissioning group will request an FOI contact from within the company.

c) Schemes which link a rebate to prescribing of more than one drug should be carefully considered to avoid the risk that savings made on one are indirectly offset by costs incurred on another.

2.3 Information and Transparency

a) Portsmouth Clinical Commissioning group will make public, via its website the existence of any rebate schemes signed up to.

b) Portsmouth Clinical Commissioning group will not enter in to any rebate schemes which preclude them from considering other schemes offered by others.

c) Details of the rebates signed up to by Portsmouth Clinical Commissioning Group scheme and discounts offered should be allowed to be shared within the NHS, if applicable.

Assessment

It is proposed that Medicines Management will assess all proposed rebate schemes that have already been assessed by the PrescQIPP Pharmaceutical Industry Scheme Governance Review Board using the checklist in appendix 1.

Process

Portsmouth Clinical Commissioning Group’s decision making process has the following steps:

  1. Only consider schemes which have gone through the PrescQIPP Pharmaceutical Industry Scheme Governance Review Board with a grey (scheme considered; no significant reservations) or amber (scheme considered; not fully appropriate) rating.
  2. Use the checklist (appendix 1) to support local decision making, fully documenting the assessment of the rebate scheme.
  3. All initial rebate schemes will be evaluated by the Medicines Management team (agree or decline). The Chief Finance Officer and the Director of Medicines Management will jointly approve each rebate scheme for use within Portsmouth Clinical Commissioning group.

3. Claiming reimbursement

Details of how to claim reimbursement will be included in the contract for individual schemes.  Portsmouth Clinical Commissioning group will generally be required to make a claim within 28 days of the end of each quarter or alternative period agreed.  Claims will be made according to the specific instructions in the agreement.

Portsmouth Clinical Commissioning group acknowledges that receipt of a rebate is a taxable event on which the CCG must declare output tax to HM Revenue & Customs.


Monitoring

A copy of the contract will be kept of all rebates or local discount schemes entered into by the Portsmouth Clinical Commissioning group together with the completed checklist and relevant paperwork.  Claims made and income from each scheme will be tracked by the Portsmouth Clinical Commissioning group Finance team.


Reference

PrescQIPP Pharmaceutical Industry Scheme Governance Review Board – operating model.
https://www.prescqipp.info/primary-care-rebates/finish/76-primary-care-rebate-governance/467-primary-care-rebate-board-operating-model

 

PrescQIPP Pharmaceutical Industry Scheme Governance Review Board.
https://www.prescqipp.info/primary-care-rebates/finish/76-primary-care-rebate-governance/2449-guidance-on-pisgrb-contractual-assessment


Appendix 1

Primary Care Rebate Scheme (PCRS) Decision Form for those rebates that have been through the PrescQIPP Pharmaceutical Industry Scheme Governance Board *Confidential*

Date:
Name of drug:
Company name:
Company contact:
Version of contract:
Assessment of good practice principlesYes/NoAdditional Comments
1. Product Related1.1Is the medicine currently included within the Portsmouth and South Eastern Hampshire area local health economy formulary and available to prescribe in Primary Care?
1.2Does the medicine have more than one licensed indication for use? (The scheme should not be linked to a particular indication for use)
1.3Is the medicine within category M or C of the Drug Tariff? (M not suitable, C consider suitability)
1.4Resilience of the product within the rebate contract – availability of the product should match the likely uptake. Reassurance will be sought that any significant increase or spike in demand can be managed by the company.
2. Rebate scheme-related2.1Is the rebate ‘price discount’ scheme?
2.2Is the termination notice 3 or 6 months?
2.3Has the proposed rebate contract been shared with the Corporate Business team for approval?
Outcome of review
No reservations
Minor reservations only – details below
Major reservations – details below
Comments:
Assessment completed by:
Date:

Approval

Director of Medicines OptimisationNameSignature
Date
Chief Finance OfficerName Signature
Date

Portsmouth CCG Medicines Management Team Rebate Policy version 2

Approved by CAG: November 2020. Review Date: November 2022.


This page was updated on 12 Nov 2020 and is due for review by 12 Nov 2021

Report an error on this page

    NHS Portsmouth Clinical Commissioning Group

    CCG Headquarters
    1 Guildhall Square
    Portsmouth
    PO1 2GJ

     

    (023) 9289 9500

    pccg.enquiries@nhs.net

     

    Media Enquiries

    pccg.media@nhs.net

    Complaints

    If you feel that your experience of NHS care has not been as positive as it should have been, you can make a formal complaint. To find out more about making a complaint, please see our complaints procedure.

    Accessibility

    You can find the Accessibility statement for Portsmouth Clinical Commissioning Group here.

    Privacy

    You can find the Fair Processing (Privacy) Notice for Portsmouth Clinical Commissioning Group here.

     

     

    Cookie Policy

    You can find the Cookie Policy for Portsmouth Clinical Commissioning Group here

    Designed and created by PortCreative 2023 ©

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    _GRECAPTCHA5 months 27 daysThis cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
    ARRAffinitysessionARRAffinity cookie is set by Azure app service, and allows the service to choose the right instance established by a user to deliver subsequent requests made by that user.
    ARRAffinitySameSitesessionThis cookie is set by Windows Azure cloud, and is used for load balancing to make sure the visitor page requests are routed to the same server in any browsing session.
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    CookieDurationDescription
    _ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
    _gat_UA-193552407-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
    _gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
    CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    CookieDurationDescription
    VISITOR_INFO1_LIVE5 months 27 daysA cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
    YSCsessionYSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
    yt-remote-connected-devicesneverYouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
    yt-remote-device-idneverYouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
    SAVE & ACCEPT
    Powered by CookieYes Logo